As of Mar 27
| +0.18 / +3.09%|
The 4 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 11.50, with a high estimate of 15.00 and a low estimate of 7.00. The median estimate represents a +91.67% increase from the last price of 6.00.
The current consensus among 4 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.